Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
Pulmonx Corporation (NASDAQ: LUNG), a leader in minimally invasive lung disease treatments, has announced its participation in the Goldman Sachs 46th Annual Global Health Care Conference. The presentation is scheduled for June 11, 2025, at 7:00 AM PT / 10:00 AM ET in Miami. Investors and interested parties can access both the live and archived webcast of the presentation through the company's investor relations website at investors.pulmonx.com.
Pulmonx Corporation (NASDAQ: LUNG), leader nelle terapie minimamente invasive per le malattie polmonari, ha annunciato la sua partecipazione alla 46陋 Conferenza Annuale Globale sulla Sanit脿 di Goldman Sachs. La presentazione 猫 prevista per il 11 giugno 2025, alle 7:00 AM PT / 10:00 AM ET a Miami. Investitori e interessati potranno seguire la diretta e accedere alla registrazione tramite il sito web delle relazioni con gli investitori all'indirizzo investors.pulmonx.com.
Pulmonx Corporation (NASDAQ: LUNG), l铆der en tratamientos m铆nimamente invasivos para enfermedades pulmonares, ha anunciado su participaci贸n en la 46陋 Conferencia Anual Global de Atenci贸n M茅dica de Goldman Sachs. La presentaci贸n est谩 programada para el 11 de junio de 2025, a las 7:00 AM PT / 10:00 AM ET en Miami. Inversionistas e interesados podr谩n acceder a la transmisi贸n en vivo y a la grabaci贸n a trav茅s del sitio web de relaciones con inversionistas de la compa帽铆a en investors.pulmonx.com.
Pulmonx Corporation (NASDAQ: LUNG)電� 斓滌唽 旃姷 韽� 歆堩櫂 旃橂 攵勳暭鞚� 靹犽憪欤检瀽搿滌劀 瓿摐毵� 靷姢 鞝�46須� 鞐半 旮�搿滊矊 項姢旒�鞏� 旎嵓霟办姢鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 氚滍憸電� 2025雲� 6鞗� 11鞚� 鞓れ爠 7鞁� PT / 鞓れ爠 10鞁� ET 毵堨澊鞎犽鞐愳劀 鞓堨爼霅橃柎 鞛堨姷雼堧嫟. 韴瀽鞛� 氚� 甏�鞁� 鞛堧姅 攵勲摛鞚� 須岇偓鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞚� investors.pulmonx.com鞐愳劀 靸濎瓿� 氚� 雲鬼檾 鞓侅儊鞚� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
Pulmonx Corporation (NASDAQ : LUNG), leader dans les traitements peu invasifs des maladies pulmonaires, a annonc茅 sa participation 脿 la 46e conf茅rence annuelle mondiale sur la sant茅 de Goldman Sachs. La pr茅sentation est pr茅vue le 11 juin 2025 脿 7h00 PT / 10h00 ET 脿 Miami. Les investisseurs et parties int茅ress茅es pourront acc茅der 脿 la diffusion en direct ainsi qu'脿 l'archive via le site des relations investisseurs de la soci茅t茅 脿 l'adresse investors.pulmonx.com.
Pulmonx Corporation (NASDAQ: LUNG), ein f眉hrendes Unternehmen im Bereich minimal-invasiver Behandlungen von Lungenerkrankungen, hat seine Teilnahme an der 46. j盲hrlichen Global Health Care Konferenz von Goldman Sachs angek眉ndigt. Die Pr盲sentation findet am 11. Juni 2025 um 7:00 Uhr PT / 10:00 Uhr ET in Miami statt. Investoren und Interessierte k枚nnen sowohl die Live-脺bertragung als auch die Aufzeichnung 眉ber die Investor-Relations-Website des Unternehmens unter investors.pulmonx.com verfolgen.
- None.
- None.
REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (鈥淧ulmonx鈥� or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Goldman Sachs 46th Annual Global Health Care Conference in Miami on Wednesday, June 11, 2025, at 7:00 AM PT / 10:00 AM ET.
A live and archived webcast of the presentation will be available on 鈥淚nvestors鈥� section of the Pulmonx website at聽.
About Pulmonx Corporation
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx鈥檚 Zephyr庐 Endobronchial Valve, Chartis庐 Pulmonary Assessment System, LungTrax鈩⒙燩latform, and StratX庐 Lung Analysis Reports are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market approval to commercialize the Zephyr Valve following its designation as a 鈥渂reakthrough device.鈥� The Zephyr Valve is commercially available in more than 25 countries, is included in global treatment guidelines and is widely considered a standard of care treatment option for improving breathing, activity and quality of life in patients with severe emphysema. For more information on the Zephyr Valves and the company, please visit .
Pulmonx庐, AeriSeal庐, Chartis庐, StratX庐, and Zephyr庐 are registered trademarks and LungTraX鈩⒙爄s a trademark of Pulmonx Corporation.
Investor Contact
Jeremy Feffer
LifeSci Advisors
FAQ
When is Pulmonx (LUNG) presenting at the Goldman Sachs Healthcare Conference 2025?
How can I watch Pulmonx's (LUNG) presentation at the Goldman Sachs Conference?
What does Pulmonx Corporation (LUNG) specialize in?
Where is the Goldman Sachs Healthcare Conference 2025 being held?
